Biolexis Therapeutics Inc. — Form D
Biolexis Therapeutics Inc. of LEHI, UT, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-17. $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-17
- Form: D
- Accession: 0001914060-23-000006
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $1.0M
- Investors: 1
- Date of first sale: 2023-10-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-495008
Issuer
- Name: Biolexis Therapeutics Inc.
- CIK: 0001914060
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 3900 N TRAVERSE MOUNTAIN BLVD SUITE 200, LEHI, UT, 84043
- Phone: 801-328-3600
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Dr. David J Bearss | Director | American Fork, UT |
| David O Taylor | Director | American Fork, UT |
| Dr. Hariprasad J Vankayalapati | Director | American Fork, UT |
| Dr. David J Bearss | Executive Officer | American Fork, UT |
| David O Taylor | Executive Officer | American Fork, UT |
| Dr. Hariprasad J Vankayalapati | Executive Officer | American Fork, UT |
| Hariprasad J Vankayalapati | Director | Sandy, UT |
| Hariprasad J Vankayalapati | Executive Officer | Sandy, UT |
| David J Bearss | Executive Officer | Sandy, UT |
| David J Taylor | Executive Officer | — |
| Tyler Hartmann | Related Person | Lehi, UT |
| David J. Bearss | Related Person | Lehi, UT |
| Hariprasad Vankayalapati | Related Person | Lehi, UT |
| James N. Clarke | Related Person | Lehi, UT |
| Anthony Steve | Related Person | Lehi, UT |
Other filings by this issuer (4)
More